Clinical Trial Regulation Conference

This conference provides a forum for information exchange and discussion on conceptual and practical questions about critical issues affecting sponsors and Member States regarding the implemention the regulation.

Back to Agenda

SESSION 3: TECHNICAL ISSUES

Session Chair(s)

Judith Creba, PhD

Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU

Novartis Pharma AG, Switzerland

Speaker(s)

Annex VI: Discussion of the Key Issues and How to Address Them

Sini Eskola, MPharm, MS, MSc

EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium

Director Regulatory Strategy

Implementation Guidance and Delegated Acts - Awareness of and the Key Identified Issues from the Draft Guidance

Isabelle Clamou

European Commission, Belgium

Policy Officer, DG SANTE Unit D2

Maja Leon-Grzymkowska